Intellia Therapeutics, Inc. short interest in 2023
In 2023, Intellia Therapeutics, Inc.'s disclosed short interest ran from 8.33% of shares outstanding on 13 Jan 2023 to 11.35% on 29 Dec 2023, a change of +3.02 percentage points. The year's high was 11.73% on 15 Dec 2023 and its low 5.94% on 31 May 2023, averaging 8.91% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.52 days on 31 Aug 2023. Full history: Intellia Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 8.33% (13 Jan 2023)
- End of year
- 11.35% (29 Dec 2023)
- Change
- +3.02 pp
- High
- 11.73% (15 Dec 2023)
- Low
- 5.94% (31 May 2023)
- Average
- 8.91%
- Highest days to cover
- 12.52 (31 Aug 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 8.33% | 5.92 | results (8-K) |
| 31 Jan 2023 | 9.35% | 5.98 | |
| 15 Feb 2023 | 9.66% | 8.38 | |
| 28 Feb 2023 | 10.30% | 6.79 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 10.02% | 5.21 | |
| 31 Mar 2023 | 9.43% | 7.26 | |
| 14 Apr 2023 | 8.86% | 6.97 | |
| 28 Apr 2023 | 7.75% | 8.05 | |
| 15 May 2023 | 6.74% | 5.44 | 10-Q filed, results (8-K) |
| 31 May 2023 | 5.94% | 4.97 | |
| 15 Jun 2023 | 6.52% | 6.02 | |
| 30 Jun 2023 | 6.88% | 4.95 | |
| 14 Jul 2023 | 7.05% | 7.69 | |
| 31 Jul 2023 | 7.23% | 9.30 | |
| 15 Aug 2023 | 8.23% | 8.52 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 8.86% | 12.52 | |
| 15 Sep 2023 | 8.74% | 9.56 | |
| 29 Sep 2023 | 9.28% | 9.96 | |
| 13 Oct 2023 | 9.17% | 8.58 | |
| 31 Oct 2023 | 10.88% | 6.70 | |
| 15 Nov 2023 | 10.58% | 5.12 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 11.00% | 6.79 | |
| 15 Dec 2023 | 11.73% | 6.13 | |
| 29 Dec 2023 | 11.35% | 7.38 |
See also: Intellia Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.